Philips Medical Systems has apparently decided that the path ofleast resistance is the wisest course to take in MRI patent litigationwith Fonar. Fonar said last month that it has settled a lawsuitfiled last year charging the Dutch vendor with infringing
Philips Medical Systems has apparently decided that the path ofleast resistance is the wisest course to take in MRI patent litigationwith Fonar. Fonar said last month that it has settled a lawsuitfiled last year charging the Dutch vendor with infringing on patentsheld by Fonar founder Dr. Raymond Damadian (SCAN 7/6/95).
Philips joins Hitachi as one of two vendors that have settledlitigation with Fonar rather than fight it out in court. Hitachi'sdecision came before Fonar won a $62 million jury verdict againstGE Medical Systems, which is on appeal. Fonar also has litigationpending against Siemens and Toshiba.
Philips initially had taken a hard line against Fonar. Thevendor, whose U.S. subsidiary is based in Shelton, CT, petitionedto join a lawsuit filed by Siemens in a Delaware court seekingto invalidate Fonar's patents (SCAN 7/19/95). Fonar's case againstSiemens is scheduled to go to trial in the summer of 1997.
Terms of Fonar's settlement with Philips were not disclosed,but they will add momentum to Fonar's plan to use the proceedsfrom patent litigation to fund a comeback in MRI based on itsnew Quad series of scanners (SCAN 10/25/95). Fonar this monthmade its first shipment of a 0.35-tesla Quad 7000 scanner, whichwas sent to an international customer, according to the company.
Despite Fonar's victories in court, a recent case demonstratesthat the Melville, NY, vendor is not invincible in the legal arena.A U.S. District Court judge in New York City late last month threwout copyright infringement claims Fonar had filed against MagneticResonance Plus, a Sacramento, CA, independent service organizationthat maintained Fonar MRI units.
The judge hearing the case ruled that Fonar had inadequatelydefined its maintenance software. This definition had been foundinsufficient in a case Fonar had filed against another ISO, DeccaidServices, according to MR Plus attorneys. MR Plus president RobertDomenick said that his company would pursue antitrust claims againstFonar.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
GE HealthCare Unveils Enhanced LesionID Pro at SNMMI Conference
Published: June 21st 2025 | Updated: June 21st 2025Emphasizing a zero-click experience, the updated LesionID Pro software, to be introduced at the SNMMI conference, reportedly provides AI-powered automated insights into whole-body tumor burden with PET and SPECT imaging.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.